Prosecution Insights
Last updated: November 20, 2026

Sarah Ann Westfall, USPTO Patent Examiner

Listed by the USPTO as WESTFALL, SARAH ANN

Tech Center 3700 • Art Units: 3791

This examiner grants 9% of resolved cases

Analysis

WESTFALL, SARAH ANN has resolved 23 cases in art unit 3791 within tech center 3700. The allowance rate is 8.7%, the median time to allowance is 1270 days, and the interview lift is 33.3%. The limited record makes the figures directional, but the allowance result indicates that applicants should expect significant examination difficulty.

The leading companies are Seoul National University Hospital, The Regents of the University of Michigan, and DexCom Inc. The leading firms are ARENTFOX SCHIFF LLP - New York, Ascenda Law Group, PC, and BIRCH STEWART KOLASCH & BIRCH, LLP. Early interviews may help identify viable claim distinctions, but should accompany a robust written response.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

8.7%
Allow Rate
-61.3% vs TC avg
71
Total Applications
+33.3%
Interview Lift
1270
Avg Prosecution Days
Based on 23 resolved cases, 2023–2026

Rejection Statute Breakdown

17.0%
§101 Eligibility
17.9%
§102 Novelty
36.0%
§103 Obviousness
26.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18717359 VASCULAR RESISTANCE AND BLOOD PRESSURE MEASUREMENT USING COMBINED PIEZOELECTRIC AND PHOTOPLETHYSMOGRAM MEASUREMENT Final Rejection REGENTS OF THE UNIVERSITY OF MICHIGAN
17974299 Ranking Feedback For Improving Diabetes Management Non-Final OA DexCom, Inc.
18601889 PREDICTION OF USER CHARACTERISTICS USING SENSOR SIGNALS Non-Final OA QUALCOMM Incorporated
17663350 DETECTION OF INFECTION BASED ON TEMPERATURE AND IMPEDANCE Final Rejection Medtronic, Inc.
18773900 HEMODYNAMIC STATE ESTIMATION METHOD Final Rejection Murata Manufacturing Co., Ltd.
17725063 SYSTEMS AND METHODS FOR DIABETES MANAGEMENT Final Rejection ABBOTT DIABETES CARE INC.
18538556 FLUID INFUSION SYSTEMS Final Rejection Medtronic MiniMed, Inc.
18047736 ENDOLUMINAL VALVE PLACEMENT PATIENT OUTCOME PREDICTION Non-Final OA GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
17782402 URINE ANALYSIS DEVICES AND METHODS FOR REAL TIME MONITORING OF KIDNEY FUNCTION Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
18715680 BRAIN WATER MONITORING METHOD AND APPARATUS BASED ON NEAR-INFRARED SPECTROSCOPY Non-Final OA SEOUL NATIONAL UNIVERSITY HOSPITAL
18037191 MEASURING AND IMPROVING ATTENTION Final Rejection Institució Catalana De Recerca I Estudis Avançats

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sarah Ann Westfall's allowance rate?

8.7% of resolved applications examined by Sarah Ann Westfall were allowed (23 resolved cases), compared with 53.4% across Art Unit 3791 over the last five years.

Does an interview help with examiner Sarah Ann Westfall?

This examiner's interview lift is +33.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sarah Ann Westfall take to allow a patent?

Applications allowed by Sarah Ann Westfall took 1,270 days on average from filing to allowance.

Which art unit does examiner Sarah Ann Westfall work in?

Sarah Ann Westfall examines applications in Art Unit 3791 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month